Haemonetics | HAE - Net Income


Haemonetics reported $44.74M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 907M 434M Jun/2026
Cerus USD -20.92M 17.98M Dec/2024
Cooper Companies USD -77.9M 208.7M Mar/2026
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Globus Medical USD 124.3M 16.29M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Intuitive Surgical USD 818.1M 3.4M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Neogen USD -11.3M 5.7M Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Quidel USD -91.8M 38.9M Mar/2026
ResMed USD 398.73M 6.14M Mar/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Steris USD 220.3M 27.4M Mar/2026
Stryker USD 1.28B 531M Jun/2026
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
US Physical Therapy USD 5.04M 885K Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026